+ Watch ROSG
on My Watchlist
The Company is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.
Swing trade after another spike. Trading stock. Long term value very questionable, short term, well above valid metrics. I did call this one up a few times. New shares issued around $5.00 helped set a floor, but may add liquidity, slowing these erratic, high beta runs. Trade between $5.30 and $6.00. Hit it on either side. May get caught at any given point. NOTE 3 month "estimate". Most likely 7-10 days and back out before this catches a low float, short covering, temporary, but painful, speculating updraft.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions